Prostate Cancer
Recent Abstracts
Angiotensin receptor blockers and risk of prostate cancer among United States Veterans - Abstract
June 27, 2013
Cardiovascular risk and bone loss in men undergoing androgen deprivation therapy for non-metastatic prostate cancer: Implementation of standardized management guidelines - Abstract
June 27, 2013
DNA ploidy measured on archived pretreatment biopsy material May correlate with prostate-specific antigen recurrence after prostate brachytherapy - Abstract
June 27, 2013
Risk of incisional hernia after minimally invasive and open radical prostatectomy - Abstract
June 27, 2013
New early detection of prostate cancer guideline toolkit now available
June 27, 2013
Post-docetaxel options for further survival benefit in metastatic castration-resistant prostate cancer: Questions of choice - Abstract
June 27, 2013
Imaging in prostate cancer - Abstract
June 26, 2013
Endorectal MRI and MR spectroscopic imaging of prostate cancer: Developing selection criteria for MR-guided focal therapy - Abstract
June 26, 2013
Screening for prostate cancer: Why, how? - Abstract
June 26, 2013
Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: Results from the European Randomized Study of Screening for Prostate Cancer Section Rotterdam - Abstr
June 26, 2013
Study of testosterone as a predictor of tumor aggressiveness in patients with prostate cancer - Abstract
June 26, 2013
Magnetic resonance image in the diagnosis and evaluation of extra-prostatic extension and involvement of seminal vesicles of prostate cancer: A systematic review of literature and meta-analysis - Abstract
June 26, 2013
Late toxicity and biochemical control in 554 prostate cancer patients treated with and without dose escalated image guided radiotherapy - Abstract
June 26, 2013
Prediction of rectum and bladder morbidity following radiotherapy of prostate cancer based on motion-inclusive dose distributions - Abstract
June 26, 2013
Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: A pharmacogenetic assessment of outcome and toxicity - Abstract
June 26, 2013
Charles G. Drake, MD, PhD of Johns Hopkins Kimmel Cancer Center takes time to share his understanding on the rationale for implementing immunotherapy in the treatment of prostate cancer
June 25, 2013
Large-cell neuroendocrine carcinoma of prostate. Case report - Abstract
June 25, 2013
Safety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer - Abstract
June 25, 2013
Preoperative erectile function is an independent predictor for decision to spare cavernous nerves during radical prostatectomy - Abstract
June 25, 2013
Differences in prostate cancer detection rates according to the level of glomerular filtration rate in patients with prostate specific antigen levels of 4.0–10.0 ng/ml - Abstract
June 25, 2013
Page 1126 of 1418
Start
Prev
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free